Results 11 to 20 of about 113,669 (290)

Adjunctive antidepressive pharmacotherapy in schizophrenia patients

European Psychiatry, 2021
Depressive symptoms during long-term course of schizophrenia constitute an important and frequent clinical problem. They may occur either as stand-alone major depressive episodes (MDEs) or as part of the schizophrenic negative syndrome.
M. Zink
doaj   +1 more source

Comparison of droperidol and haloperidol for acute agitation in the emergency department: A retrospective cohort study [PDF]

Mental Health Clinician
Introduction To compare the effectiveness of droperidol and haloperidol for acute agitation in the emergency department. Methods Data from electronic health records were collected from January 1, 2022, to August 25, 2023, across 6 emergency departments ...
Francesca DiGuglielmo, PharmD, Melanie D’Amico, PharmD, BCPS, Julianne Martine, PharmD, BCPS, Craig Sastic, PharmD, MBA, BCP, Tiffany Vuong, PharmD, BCPS, MTM-C   +4 more
doaj   +1 more source

Challenges in schizoaffetive disorder therapeutic – a case report of a patient with hiperprolactinemia

European Psychiatry, 2021
Introduction The only FDA approval therapeutic for schizoaffective disorder is paliperidone. Hiperprolactinemia is one of the most frequent side effects induced by first generation antipsychotics (FGA) or by second generation antipsychotic (SGA), such ...
D. Rodrigues, D. Jeremias, C. Laginhas, A. Sequeira   +3 more
doaj   +1 more source

Antipsychotics for irritability in children with Autism Spectrum Disorders

European Psychiatry, 2022
Introduction Autism is a neurodevelopmental disorder characterized by qualitative impairments in social interaction, communication, and restricted and repetitive behaviors [1]. Despite of these symptoms, some patients present different manifestations of
V. Muñoz Martinez, L. Beato-Fernández, E. Segura-Escobar   +2 more
doaj   +1 more source

Dosage of antipsychotics in China routine practice

European Psychiatry, 2021
Introduction The antipsychotic dosage of Chinese schizophrenia patients has rarely been studied, although nonstandard dosage has impact on prognosis. Objectives To describe the dosage of antipsychotics in China routine practice.
T. Zhang, R. Chi, T. Wu, Y. Xu, W. Dong
doaj   +1 more source

Tobacco dependence and schizophrenia: Tunisian cross-sectional study of 50 cases

European Psychiatry, 2022
Introduction Tobacco-use is currently one of the major public health problems and is more common among patients with schizophrenia. Objectives We aimed in this study to estimate the prevalence of smoking in a population of patients with schizophrenia ...
M. Jabeur, L. Gassab, I. Anes, A. Ben Haouala, F. Zaafrane, L. Gaha   +5 more
doaj   +1 more source

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting

Journal of Market Access & Health Policy, 2017
Background: Adverse event (AE) reporting in clinical trials does not fully capture the patient-level perspective and comparing tolerability across treatments or among studies is difficult.
Clément François, Alice Guiraud-Diawara, Christophe Lançon, Pierre Michel Llorca, Ann Hartry, Lene Hammer-Helmich, Djamel A. Zighed, Adrian Tanasescu, Mondher Toumi   +8 more
doaj   +1 more source

Treatment of early onset schizophrenia: Recent trends, challenges and future considerations

Frontiers in Psychiatry, 2012
Early onset schizophrenia (onset before adulthood) is a rare, severe and chronic form of schizophrenia. Antipsychotic treatment remains the mainstay of treatment although current medications provide suboptimal response at best.
Nora S Vyas, Nitin eGogtay
doaj   +1 more source

Quetiapine-induced bicytopenia. Case report and literature review

European Psychiatry, 2021
Introduction Low white blood cell counts and agranulocytosis are a relatively rare side effect of atypical antipsychotic treatment. Like most atypical antipsychotics, quetiapine only has a 1%-4% risk of low blood cell count.
T. Gutiérrez Higueras, S. Vicent Forés, S. Sainz De La Cuesta Alonso, F. Calera Cortés   +3 more
doaj   +1 more source

A randomized-controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia

Frontiers in Pharmacology, 2013
Objective: Medication adherence is extremely important in preventing relapse and lowering symptoms in schizophrenic patients. However, estimates show that nearly half of these patients have poor adherence. The Brief Adherence Rating Scale (BARS) seems to
Emmanuel eStip, Emmanuel eStip, Emmanuel eStip, Philippe D. Vincent, Philippe D. Vincent, Philippe D. Vincent, Catherine eGuevremont, Simon eZhornitsky, Constantin eTranulis, Constantin eTranulis, Constantin eTranulis, Juliette eSablier, Juliette eSablier   +12 more
doaj   +1 more source